Molecule Details
| InChIKey | URPHWXWGWHZRLT-UHFFFAOYSA-N |
|---|---|
| Compound Name | 3-Methoxy-5-((4-((4-(3-(1-(4-methoxyphenyl)-3-(prop-1-en-2-yl)-1H-pyrazol-5-yl)ureido)naphthalen-1-yl)oxy)pyrimidin-2-yl)amino)-N-(2-morpholinoethyl)-benzamide |
| Canonical SMILES | C=C(C)c1cc(NC(=O)Nc2ccc(Oc3ccnc(Nc4cc(OC)cc(C(=O)NCCN5CCOCC5)c4)n3)c3ccccc23)n(-c2ccc(OC)cc2)n1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 3 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.93 |
| Source | ChEMBL;BindingDB |
2D Structure
Activity Profile